PMID- 17114809 OWN - NLM STAT- MEDLINE DCOM- 20070307 LR - 20210209 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 282 IP - 2 DP - 2007 Jan 12 TI - Tumor necrosis factor-alpha-stimulated cell proliferation is mediated through sphingosine kinase-dependent Akt activation and cyclin D expression. PG - 863-70 AB - Tumor necrosis factor-alpha (TNF-alpha) has been shown to activate sphingosine kinase (SphK) in a variety of cell types. The extent to which SphK signaling mediates the pleiotropic effects of TNF-alpha is not entirely clear. The current study examined the role of SphK activity in TNF-alpha-stimulated cell proliferation in 1321N1 glioblastoma cells. We first demonstrated that pharmacological inhibitors of SphK markedly decrease TNF-alpha-stimulated DNA synthesis. Signaling mechanisms through which SphK mediated the effect of TNF-alpha on DNA synthesis were then examined. Inhibition of Rho proteins with C3 exoenzyme or of Rho kinase with Y27632 attenuated TNF-alpha-stimulated DNA synthesis. However, RhoA activation by TNF-alpha was not blocked by SphK inhibition. ERK activation was also required for TNF-alpha-stimulated DNA synthesis but likewise TNF-alpha-induced ERK activation was not blocked by inhibition of SphK. Thus, neither RhoA nor ERK activation are the SphK-dependent transducers of TNF-alpha-induced proliferation. In contrast, TNF-alpha-stimulated Akt phosphorylation, which was also required for DNA synthesis, was attenuated by SphK inhibition or SphK1 knockdown by small interfering RNA. Furthermore, cyclin D expression was increased by TNF-alpha in a SphK- and Akt-dependent manner. Additional studies demonstrated that TNF-alpha effects on DNA synthesis, ERK, and Akt phosphorylation are not mediated through cell surface Gi -coupled S1P receptors, because none of these responses were inhibited by pertussis toxin. We conclude that SphK-dependent Akt activation plays a significant role in TNF-alpha-induced cyclin D expression and cell proliferation. FAU - Radeff-Huang, Julie AU - Radeff-Huang J AD - Department of Pharmacology, University of California, San Diego, La Jolla, California 92093, USA. FAU - Seasholtz, Tammy M AU - Seasholtz TM FAU - Chang, Jenny W AU - Chang JW FAU - Smith, Jeffrey M AU - Smith JM FAU - Walsh, Colin T AU - Walsh CT FAU - Brown, Joan Heller AU - Brown JH LA - eng GR - GM36927/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20061119 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Cyclin D) RN - 0 (Cyclins) RN - 0 (RNA, Small Interfering) RN - 0 (Receptors, Cell Surface) RN - 0 (Receptors, Lysosphingolipid) RN - 0 (Tumor Necrosis Factor-alpha) RN - 9007-49-2 (DNA) RN - EC 2.7.1.- (Phosphotransferases (Alcohol Group Acceptor)) RN - EC 2.7.1.- (sphingosine kinase) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 3.6.5.2 (rho GTP-Binding Proteins) SB - IM MH - Brain Neoplasms MH - Cell Division/drug effects/physiology MH - Cell Line, Tumor MH - Cyclin D MH - Cyclins/*metabolism MH - DNA/biosynthesis MH - Enzyme Activation/drug effects/physiology MH - Glioblastoma MH - Humans MH - Phosphotransferases (Alcohol Group Acceptor)/genetics/*metabolism MH - Proto-Oncogene Proteins c-akt/*metabolism MH - RNA, Small Interfering MH - Receptors, Cell Surface/metabolism MH - Receptors, Lysosphingolipid/metabolism MH - Signal Transduction/drug effects/*physiology MH - Tumor Necrosis Factor-alpha/*metabolism/pharmacology MH - rho GTP-Binding Proteins/metabolism EDAT- 2006/11/23 09:00 MHDA- 2007/03/08 09:00 CRDT- 2006/11/23 09:00 PHST- 2006/11/23 09:00 [pubmed] PHST- 2007/03/08 09:00 [medline] PHST- 2006/11/23 09:00 [entrez] AID - S0021-9258(20)73511-8 [pii] AID - 10.1074/jbc.M601698200 [doi] PST - ppublish SO - J Biol Chem. 2007 Jan 12;282(2):863-70. doi: 10.1074/jbc.M601698200. Epub 2006 Nov 19.